Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01044290 · ClinicalTrials.gov registry record · NA

Outlook Quality of Life Intervention Study

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
221
Enrollment target

NCT01044290: Completed NA study, sponsored by VA Office of Research and Development.

NCT01044290 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 221 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01044290, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
221 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Primary Outcome

Quality Of Life At The End Of Life (the QUAL-E 2009) is a 31 item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. We include the 4-item preparation sub-scale as a primary outcomes measure. Individual items used a 5 point likert scale. The sub-scale minimum score was 5 and maximum was 20 with higher numbers indicating higher preparation.

Interventions

  • OTHER Attention Control
  • OTHER Life Completion

Trial Details

FieldValue
Enrollment Target 221 participants
Start Date 2011-01
Est. Completion 2014-04
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01044290 record still lists

NCT01044290 is an interventional study that assigns participants to a tested intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.

NCT01044290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01044290 about?

NCT01044290 is a clinical study titled "Outlook Quality of Life Intervention Study". The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

What is the current status of trial NCT01044290?

This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2011-01. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01044290?

The interventions under investigation include: Attention Control (OTHER), Life Completion (OTHER).

Who is sponsoring clinical trial NCT01044290?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01044290's enrollment target sits among peer trials

221 481st of 2000 higher than 1,520 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03170440 · 221 participants · NA

    Non-invasive Nerve Stimulation for PTSD and Sleep

  • NCT04939610 · 222 participants · Phase 1

    A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

  • NCT05424783 · 222 participants

    MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

  • NCT05568264 · 222 participants · NA

    Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01044290, the US trial registry maintained by the National Library of Medicine. NCT01044290 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.